Sunapten Therapeutics

Sunapten Therapeutics is an early stage pharmaceutical company developing a vaccine to treat prostate cancer patients by a simple injection, much like any traditional vaccine for tetanus or influenza. The advantage of this therapy in comparison to traditional vaccines is that the innovative technology behind Sunapten's vaccine allows for the rapid neutralization of the therapeutic immune response, should an unexpected adverse response be detected.